BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5591740)

  • 1. [Clinical observations and experimental findings in the treatment of hyperinsulinism with diazoxide].
    Frerichs H; Creutzfeldt C; Creutzfeldt W
    Verh Dtsch Ges Inn Med; 1967; 73():1086-91. PubMed ID: 5591740
    [No Abstract]   [Full Text] [Related]  

  • 2. [Continuous treatment with diazoxide of hypoglycemia due to hyperinsulinism].
    Loyau G; Kopp J; Sauvalle A; Porin J
    Sem Hop; 1970 Jun; 46(27):1907-10. PubMed ID: 4316119
    [No Abstract]   [Full Text] [Related]  

  • 3. Diazoxide for hyperinsulinism.
    Drug Ther Bull; 1970 Mar; 8(6):23-4. PubMed ID: 5440617
    [No Abstract]   [Full Text] [Related]  

  • 4. Persistent neonatal hyperinsulinemic hypoglycemia in two siblings successfully treated with diazoxide.
    Wüthrich C; Schubiger G; Zuppinger K
    Helv Paediatr Acta; 1986 Dec; 41(5):455-9. PubMed ID: 3818333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term diazoxide therapy in recurrent leucine-sensitive hypoglycemia (author's transl)].
    Maertens P; de Geeter B; Kurtz F; Messer J; Raber A; Willard D
    Ann Pediatr (Paris); 1980 Dec; 27(10):677-81. PubMed ID: 7212555
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental demonstration of the mechanism of action of a hyperglycemic sulfonamide: diazoxide. Basis of its use for the treatment of sever hypoglycemia due to hypersecretion of insulin].
    Loubatières A
    Bull Acad Natl Med; 1966 Nov 8-15; 150(28):591-601. PubMed ID: 4865452
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic effects of diazoxide in normal subjects, patients with diabetes mellitus, and patients with organic hypoglycemia.
    Steinke J; Soeldner JS
    Ann N Y Acad Sci; 1968 Apr; 150(2):326-36. PubMed ID: 4299223
    [No Abstract]   [Full Text] [Related]  

  • 8. Palliative treatment of hyperinsulinism with cyproheptadine and diazoxide.
    Rotenstein D; Serbin S; Welsh T
    Pediatrics; 1992 Aug; 90(2 Pt 1):212-5. PubMed ID: 1379358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlorpromazine in the treatment of endogenous organic hyperinsulinism.
    Federspil G; Casara D; Stauffacher W
    Diabetologia; 1974 Jun; 10(3):189-91. PubMed ID: 4845719
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of hyperinsulinism after partial pancreatectomy: medical or surgical?
    Schnatz JD; Siegel JH
    J Med; 1978; 9(5):365-75. PubMed ID: 284080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoglycemia due to hyperinsulinism treated by streptozotocin and diazoxide.
    Harrell A; Laurian L; Ayalon D; Kisch E; Cordova T
    Isr J Med Sci; 1972 Jun; 8(6):895-6. PubMed ID: 4340671
    [No Abstract]   [Full Text] [Related]  

  • 12. The treatment of hypoglycaemia with diazoxide.
    Samols E; Marks V
    Proc R Soc Med; 1966 Sep; 59(9):811-4. PubMed ID: 5921562
    [No Abstract]   [Full Text] [Related]  

  • 13. Diazoxide therapy in the syndrome of Beckwith-Weidemann-Coombs.
    Gotlin RW
    J Pediatr; 1973 Aug; 83(2):342-3. PubMed ID: 4717592
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical studies in the use of oral diazoxide in postsurgical and functional hypoglycemia.
    Wales JK; Spechtmeyer H; Viktora JK; Wolff FW
    Med Ann Dist Columbia; 1968 Sep; 37(9):460-8. PubMed ID: 5248391
    [No Abstract]   [Full Text] [Related]  

  • 15. Diazoxide in the treatment of infantile hypoglycemia.
    Mereu TR; Kassoff A; Goodman AD
    N Engl J Med; 1966 Dec; 275(26):1455-60. PubMed ID: 5956372
    [No Abstract]   [Full Text] [Related]  

  • 16. Reversal of impaired counterregulatory cortisol response following diazoxide treatment in a patient with non insulinoma pancreatogenous hypoglycemia syndrome: Case report and overview of pathogenetic mechanisms.
    Fountoulakis S; Malliopoulos D; Papanastasiou L; Pappa T; Karydas G; Piaditis G
    Hormones (Athens); 2015; 14(2):305-11. PubMed ID: 25402390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of Proglicem in patients with an organic hyperinsulinism syndrome].
    Sindelka G; Skrha J; Svacina S; Justová V; Wichterle D
    Cas Lek Cesk; 1994 Jan; 133(2):53-5. PubMed ID: 8131181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of diazoxide in hypoglycemia with hyperinsulinemia in hemodialysis.
    Arenas Jiménez MD; Navarro Tellez P
    Nefrologia (Engl Ed); 2018; 38(2):220-221. PubMed ID: 29203064
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of organic hyperinsulinism with diazoxide].
    Kolesár P
    Vnitr Lek; 1979 Nov; 25(11):1099-102. PubMed ID: 516490
    [No Abstract]   [Full Text] [Related]  

  • 20. [Potentiation of the effects of diazoxide by chlorpromazine in the treatment of organic hyperinsulinism].
    Vague PH; Vialettes B
    Nouv Presse Med; 1977 May; 6(21):1883. PubMed ID: 876839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.